Newsroom

LONDON--(BUSINESS WIRE)--The latest research from Omdia shows that US PC shipments (excluding tablets) grew 3% year-on-year in Q4 2025 to 18.2 million units, reversing two consecutive quarters of annual decline. The return to growth was driven by a combination of the peak of Windows 11 commercial refreshes, holiday-season demand, and vendor efforts to secure inventory ahead of anticipated memory and storage supply constraints in 2026. Full-year 2025 shipments reached 71.5 million units, up 3% f...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust IPOX Europe Equity Opportunities UCITS ETF 27.03.2026 IPXE.IM IE00BFD26097 50,002.00 EUR 1,111,696.29 22.233  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Cloud Computing UCITS ETF 27.03.2026 CPQ IE00BFD2H405 7,625,002.00 USD 339,491,013.50 44.523  ...

SAN DIEGO--(BUSINESS WIRE)--Jack in the Box Inc. (“Jack in the Box” or the “Company”) (NASDAQ: JACK), today announced that it has appointed Katelyn Zborowski as the Company’s new Chief Marketing Officer, effective today. Zborowski will lead the Company’s marketing strategy, with a focus on driving demand through innovation, delivering profitable value, and bringing Jack’s Way to life across the brand. Zborowski is a consumer-led marketing executive with over 15 years of experience delivering ca...

NEW YORK--(BUSINESS WIRE)--Capstone Holding Corp. (NASDAQ: CAPS), a tech-enabled building products distribution platform, today announced that the integration of KLAD Envelope Solutions, its architectural representative business, is expanding the Company’s commercial reach and supporting high-margin sales growth. The integration gives Capstone direct access to commercial customers and is expected to drive proprietary product sales into large-scale projects across multiple geographies. “KLAD’s r...

AUBURN HILLS, Mich.--(BUSINESS WIRE)--PHINIA Inc. (NYSE: PHIN), a leader in premium fuel systems, electrical systems, and aftermarket solutions will report first quarter 2026 earnings results on Thursday, April 30, 2026. PHINIA’s earnings press release, earnings presentation and other materials will be available at the “Investors” section of PHINIA’s website, PHINIA - Investor Relations. PHINIA will host a webcast to review first quarter 2026 results and take questions from the investment commu...

BOSTON--(BUSINESS WIRE)--Sensei Biotherapeutics, Inc. (Nasdaq: SNSE) today reported financial results for the full year ended December 31, 2025, following its previously announced acquisition of Faeth Therapeutics and concurrent $200 million private placement. The financing, together with the Company's cash on hand, is expected to support advancement of PIKTOR through key clinical milestones, including topline data readouts from both the ongoing Phase 2 trial in advanced endometrial cancer (Stu...

ALBANY, N.Y.--(BUSINESS WIRE)--Soluna Holdings, Inc. (“Soluna Holdings” or the “Company”) (NASDAQ: SLNH), a developer of green data centers for intensive computing applications, including Bitcoin mining and AI, announced financial results for the full year ended December 31, 2025. “2025 was a transformational year for Soluna. We doubled our operating capacity, grew our power pipeline to 4.3GW, added two new project-level capital partners, and launched our AI infrastructure initiative — all whil...

SMITH FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC) today announced that its Apollo Cannabis Clinics (“Apollo”) has been named Best Medical Cannabis Clinic in the 2025 Toronto Star’s Readers’ Choice Awards, a public vote that reflects the trust patients place in Apollo’s care. Apollo represents the Company’s commitment to raising the standard of medical cannabis and making quality treatment accessible to every Canadian. “...

NEW HAVEN, Conn.--(BUSINESS WIRE)--Veradermics, Incorporated (NYSE: MANE), a dermatologist-founded, late clinical-stage biopharmaceutical company focused on developing innovative therapeutics for common aesthetic and dermatological conditions, today reported financial results for the fourth quarter and full year periods ended December 31, 2025, and announced recent corporate and clinical updates. “2025 was a landmark year for Veradermics, marked by significant progress in advancing Phase 3 deve...